Ontology highlight
ABSTRACT:
SUBMITTER: Kim MS
PROVIDER: S-EPMC6291404 | biostudies-literature | 2018 Dec
REPOSITORIES: biostudies-literature
Kim Myung Soo MS Chung Ho Seok HS Hwang Eu Chang EC Jung Seung Il SI Kwon Dong Deuk DD Hwang Jun Eul JE Bae Woo Kyun WK Park Jae Young JY Jeong Chang Wook CW Kwak Cheol C Song Cheryn C Seo Seong Il SI Byun Seok-Soo SS Hong Sung-Hoo SH Chung Jinsoo J
Journal of Korean medical science 20181122 51
<h4>Background</h4>To evaluate survival outcomes and prognostic factors for overall survival (OS) in patients with metastatic renal cell carcinoma (mRCC) who received sunitinib (SU) and pazopanib (PZ) as first-line therapy in real-world Korean clinical practice.<h4>Methods</h4>Data of 554 patients with mRCC who received SU or PZ at eight institutions between 2012 and 2016 were retrospectively reviewed. Based on the targeted therapy, the patients were divided into SU (n = 293) or PZ (n = 261) gro ...[more]